Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WE SENSE: Wearable Sensors for VRTI Detection
NCT05290792Completed
- Start
- Dec 2021
- Primary completion
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza. Primary endpoints: Heart rate at 14 days, Heart rate variability at 14 days and 5 more. Started Dec 2021; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05290792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05290792.